Purpose of the ADVANCE Study.

The purpose of the study is to determine the safety and effectiveness of an investigational medication for agitation in patients with Alzheimer’s disease.

Who may qualify.

The ADVANCE Study is open to those who meet the following criteria:

  • Are 65 to 90 years of age
  • Have a diagnosis of probable Alzheimer’s disease
  • Have a diagnosis of clinically significant agitation
  • Have a caregiver who is willing and able to comply with the study instructions

Study schedule.

Participants in the ADVANCE Study will:

  • Attend six in-office visits and one follow-up visit over the phone
  • Receive the study drug twice daily for five weeks

Caregivers in the ADVANCE Study will need to:

  • Accompany the participant to all study visits
  • Complete a brief daily diary

Message for caregivers.

See if your loved one may qualify